RxSight (RXST) Minority Interest (2020 - 2021)
RxSight (RXST) posted Minority Interest of $353.3 million for Q2 2021, little changed on a QoQ basis from $353.3 million in Q4 2020.
RxSight (RXST) Minority Interest (2020 - 2021) Analysis & Trends
RxSight's Minority Interest history runs 2 years deep, the most recent figure standing at $353.3 million for Q2 2021.
- Quarterly Minority Interest changed N/A year-over-year to $353.3 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $353.3 million (changed N/A YoY) and the FY2020 annual result came in at $353.3 million, changed N/A from the prior year.
- Minority Interest was $353.3 million for Q2 2021 at RxSight, roughly flat from $353.3 million in the prior quarter.
- Across five years, Minority Interest topped out at $353.3 million in Q4 2020 and bottomed at $353.3 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | RxSight | 221.81 Mn | -196.39 Mn | 23.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 353.30 Mn |
| Dec 31, 2020 | 353.30 Mn |